Menu

1 / 8

Leukemia vaccine passes key trial, adding to breakthrough year for cancer drugs

Business - Latest - Google News·1 day ago
#ol232tgy
#world#news#washingtonpost#leukemia#cancer
Reading 0:00
15s threshold

Democracy Dies in Darkness

The vaccine reduced risk of death for certain acute myeloid leukemia patients, according to drugmaker.

November 17, 2026 at 5:38 p.m. EST10 minutes ago

Light microscope image of blood smear indicating leukemia. (Southern Illinois University/Science Source)

A first of its kind vaccine for acute myeloid leukemia, a deadly blood cancer, succeeded in a Phase 3 clinical trial, drugmaker Sellas Life Sciences and Memorial Sloan Kettering Cancer Center announced Tuesday, marking another positive result in a breakthrough year for cancer vaccines.